Mercer Global Advisors
INO icon

Mercer Global Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Mercer Global Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109 Buy
+99
New +$117 ﹤0.01% 5966

Other funds holding INO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $149M AUM 118.1% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return

Mercer Global Advisors's INO Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 99 shares worth $109. The stake represents ﹤0.01% of the portfolio and ranks #5966 among its holdings.

50 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Mercer Global Advisors held 99 shares of Inovio Pharmaceuticals worth $109 as of Q2 2026.
  • Inovio Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5966 holding.
  • 50 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.